OpenAlex
PricingAboutJobs
Log inGet started
Work

Harnessing innate immunity in cancer therapy

HTML

Year: 2019
Type: review
Source: Nature
DOI: 10.1038/s41586-019-1593-5
Authors: Olivier Demaria, Stéphanie Cornen, Marc Daëron, Yannis Morel, Ruslan Medzhitov, Eric Vivier
Institutions: Innate Pharma (France), Centre National de la Recherche Scientifique, Inserm, Institut Pasteur, Aix-Marseille Université, Centre d’Immunologie de Marseille-Luminy, Howard Hughes Medical Institute, Yale University, Assistance Publique Hôpitaux de Marseille, Hôpital de la Timone
Language: English

Topic: Immunotherapy and Immune Responses
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Keywords: innate immunity, antitumor immunity, cancer immunotherapy, innate immune cells, natural killer cells, dendritic cells, macrophages, tumour-associated macrophages, T cell response, chimeric antigen receptor T cells, bispecific antibodies, immunomodulation
SDG: Good health and well-being

Open Access status: closed

Funder: Agence Nationale de la Recherche
Award: Precision Immuno-Oncology for advanced Non small cell lung cancer patients with PD-1 ICI Resistance
OpenAlex ID: W2977255036
FWCI: 7.62
Cites: 212
Cited by: 1,048
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security